Point72 Asia (Singapore)’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$617	Buy	+44	New	+$617	﹤0.01%	833
2024 Q4	–	Sell	-6,543	Closed	-$149K	–	1248
2024 Q3	$149K	Buy	+6,543	New	+$149K	0.03%	441